Comparison of Spectral-Domain versus Time-Domain Optical Coherence Tomography in Management of Age-Related Macular Degeneration with Ranibizumab

Ophthalmology

Volumn 116, Issue 5, 2009, Pages 947-955

  Sayanagi, Kaori ^a   Sharma, Sumit ^a   Yamamoto, Takuhiro ^a   Kaiser, Peter K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

AGED; ARTICLE; B SCAN; CASE REPORT; CASE STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; MALE; OPTICAL COHERENCE TOMOGRAPHY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; THICKNESS; THREE DIMENSIONAL IMAGING;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; PROSPECTIVE STUDIES; RETINA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 67349108048     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.11.002     Document Type: Article

References (20)

1. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122 (2004) 564-572
2. Kaiser P.K., and Do D.V. Ranibizumab for the treatment of neovascular AMD. Int J Clin Pract 61 (2007) 501-509
3. Rosenfeld P.J., Brown D.M., Heier J.S., et al., MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1419-1431
4. Brown D.M., Kaiser P.K., Michels M., et al., ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 55 (2006) 1432-1444
5. Van de Moere A., Sandhu S.S., and Talks S.J. Correlation of optical coherence tomography and fundus fluorescein angiography following photodynamic therapy for choroidal neovascular membrane. Br J Ophthalmol 90 (2006) 304-306
6. Eter N., and Spaide R.F. Comparison of fluorescein angiography and optical coherence tomography for patients with choroidal neovascularization after photodynamic therapy. Retina 25 (2005) 691-696
7. Fung A.E., Lalwani G.A., Rosenfeld P.J., et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 143 (2007) 566-583
8. Wojtkowski M., Leitgeb R., Kowalczyk A., et al. In vivo human retina imaging by Fourier domain optical coherence tomography. J Biomed Opt 7 (2002) 457-463
9. Nassif N., Cense B., Park B.H., et al. In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. Opt Lett 29 (2004) 480-482
10. Leitgeb R., Drexler W., Unterhuber A., et al. Ultrahigh resolution Fourier domain optical coherence tomography. Opt Express [serial online] 12 (2004) 2156-2165. http://www.opticsinfobase.org/oe/abstract.cfm?uri=oe-12-10-2156 Accessed November 2, 2008.
11. Chen T.C., Cense B., Pierce M.C., et al. Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging. Arch Ophthalmol 123 (2005) 1715-1720
12. Regillo C.D., Brown D.M., Abraham P., et al., PIER Study Group. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol 145 (2008) 239-248
13. Friedman S.M., and Margo C.E. Choroidal neovascular membranes: reproducibility of angiographic interpretation. Am J Ophthalmol 130 (2000) 839-841
14. Hole F.G., Jorzik J., Schutt F., et al. Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP-study). Ophthalmology 110 (2003) 400-405
15. van Velthoven M.E., de Smet M.D., Schlingemann R.O., et al. Added value of OCT in evaluating the presence of leakage in patients with age-related macular degeneration treated with PDT. Graefes Arch Clin Exp Ophthalmol 244 (2006) 1119-1123
16. Zhang N., Hoffmeyer G.C., Young E.S., et al. Optical coherence tomography reader agreement in neovascular age-related macular degeneration. Am J Ophthalmol 144 (2007) 37-44
17. Forooghian F., Cukras C., Meyerle C.B., et al. Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci 49 (2008) 4290-4296
18. Leung C.K., Cheung C.Y., Weinreb R.N., et al. Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 49 (2008) 4893-4897
19. Ray R., Stinnett S.S., and Jaffe G.J. Evaluation of image artifact produced by optical coherence tomography of retinal pathology. Am J Ophthalmol 139 (2005) 18-29
20. Leung C.K., Chan W.M., Chong K.K., et al. Alignment artifacts in optical coherence tomography analyzed images. Ophthalmology 114 (2007) 263-270